We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Unsuccessful Fertility Treatments Not Linked With Depression

By HospiMedica International staff writers
Posted on 11 Aug 2015
A new study reveals that unsuccessful fertility treatment is not linked with an increased risk of clinically diagnosed depression.

Researchers at the University of Copenhagen (KU; Denmark) and Rigshopitalet University Hospital (Copenhagen, Denmark) conducted a study that analyzed data on more than 41,050 women registered in the Danish National ART-Couple (DANAC) cohort, who received assisted reproductive technology (ART) treatment from January 1, 1994, to September 30, 2009. More...
Concomitantly, they reviewed information on unipolar depression obtained from the Danish Psychiatric Central Research Register.

The results revealed that during the 308,494 person-years of follow up, 552 of the women were diagnosed with unipolar depression. Analysis showed that women in ART treatment, with no live birth as yet, had a lower risk of unipolar depression compared with women who completed a live birth, who faced the highest risk of unipolar depression 0–42 days after a live birth. A lower, but still present risk was found in women 43 days and onward post-birth, compared with women with no live birth.

The researchers concluded that becoming a mother is an important trigger of clinically diagnosed depression after childbirth among women who conceive after ART fertility treatment, even though the child is long-awaited. The stress of having a new child thus seems to end up mattering more—in terms of developing clinical depression—than undergoing the infertility treatment. The study was published on august 3, 2015, in Acta Obstetricia et Gynecologica Scandinavica.

“These findings regard the most severe cases of depression diagnoses as the women are all diagnosed and treated in a hospital setting,” said lead author Camilla Sejbaek, PhD, of the KU department of public health. “It is important to remember that fertility treatment is straining; however, our findings showed that women undergoing assisted reproductive fertility treatment are at risk of clinically diagnosed severe depression after a child birth.”

The commonly used term postpartum depression (PPD) no longer exists as a diagnosis, and is now defined by the DSM-5 as a depressive disorder with peripartum onset, starting anytime during pregnancy or within the four weeks following delivery. The distinction made between depressive episodes during pregnancy or those that occur after delivery is no longer made. Symptoms may include sadness, low energy, changes in sleeping and eating patterns, reduced sex drive, crying episodes, anxiety, and irritability.

Related Links:

University of Copenhagen
Rigshopitalet University Hospital



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.